◼ Archived
Business
🔮 holds ✗
CAR-T
2 independently sourced, verified news trends involving CAR-T.
Coverage evidence
This hub is built from stories supported by at least four independent sources and accepted by Newsylist's verification pass. Qualifying coverage spans 2 news categories, from Jul 1, 2026 through Sep 25, 2026.
Open any card for the source list, timeline and coverage-velocity evidence. Raw detections and extractive-only records are excluded from this page.
◼ Archived
Health
🔮 holds ✗
Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells
Researchers are testing a dual-targeting GPNMB CAR-T cell therapy to treat aggressive glioblastoma and its supporting immune cells.